Autocorrection If→of Function Words in Reading Aloud: A Novel Marker of Alzheimer's Risk
Overview
Affiliations
Objective: The present study investigated cognitive mechanisms underlying the ability to stop "autocorrect" errors elicited by unexpected words in a read-aloud task, and the utility of autocorrection for predicting Alzheimer's disease (AD) biomarkers.
Method: Cognitively normal participants (total = 85; = 64 with cerebrospinal fluid [CSF] biomarkers) read aloud six short paragraphs in which 10 critical target words were replaced with autocorrect targets, for example, . Autocorrect targets either replaced the most expected/ completion (i.e., ) or a less expected/ completion (i.e., ), and within each paragraph half of the autocorrect targets were content words (e.g., ) and half were function words (e.g., ). Participants were instructed to avoid autocorrecting.
Results: Participants produced more autocorrect errors in paragraphs with dominant than with nondominant targets, and with function than with content targets. Cognitively normal participants with high CSF Tau/Aβ42 (i.e., an AD-like biomarker profile) produced more autocorrect total errors than those below the Tau/Aβ42 threshold, an effect also significant with dominant-function targets alone (e.g., saying instead of ). A logistic regression model with dominant-function errors and age showed errors as the stronger predictor of biomarker status (sensitivity 83%; specificity 85%).
Conclusions: Difficulty stopping autocorrect errors is associated with biomarkers indicating preclinical AD, and reveals promise as a diagnostic tool. Greater vulnerability of function over content words to autocorrection in individuals with AD-like biomarkers implicates monitoring and attention (rather than semantic processing) in the earliest of cognitive changes associated with AD risk. (PsycInfo Database Record (c) 2023 APA, all rights reserved).
Estimating the rate of failure to notice function word errors in natural reading.
Staub A, Chen A, Peck E, Taylor N Psychon Bull Rev. 2024; .
PMID: 39349743 DOI: 10.3758/s13423-024-02586-1.
Garcia D, Gollan T Neuropsychology. 2024; 38(4):322-336.
PMID: 38330361 PMC: 11035100. DOI: 10.1037/neu0000943.